134 related articles for article (PubMed ID: 38306539)
1. Extra-abdominal infections caused by Comamonas kerstersii: Case report.
Wang M; Wang H; Chen S; Ming D; Nie Q
Medicine (Baltimore); 2024 Feb; 103(5):e37161. PubMed ID: 38306539
[TBL] [Abstract][Full Text] [Related]
2. Intra-abdominal infections due to Comamonas kerstersii.
Almuzara MN; Cittadini R; Vera Ocampo C; Bakai R; Traglia G; Ramirez MS; del Castillo M; Vay CA
J Clin Microbiol; 2013 Jun; 51(6):1998-2000. PubMed ID: 23576541
[TBL] [Abstract][Full Text] [Related]
3. Comamonas kerstersii bacteremia in a patient with acute perforated appendicitis: A rare case report.
Zhou YH; Ma HX; Dong ZY; Shen MH
Medicine (Baltimore); 2018 Mar; 97(13):e9296. PubMed ID: 29595695
[TBL] [Abstract][Full Text] [Related]
4. First report of urinary tract infection caused by Comamonas kerstersii in a goat.
Pavone S; Rinoldo R; Albini E; Fiorucci A; Caponi B; Fratto A; Manuali E; Papa P; Magistrali CF
BMC Vet Res; 2021 Mar; 17(1):133. PubMed ID: 33766029
[TBL] [Abstract][Full Text] [Related]
5. A young child with acute perforated appendicitis due to
Bennani H; El Ouarradi A; Hanchi AL; Soraa N
Pan Afr Med J; 2022; 41():186. PubMed ID: 35655686
[TBL] [Abstract][Full Text] [Related]
6. [Comamonas kerstersii bacteremia in a young man with acute appendicitis].
Palacio R; Cabezas L; Cornejo C; Seija V
Rev Chilena Infectol; 2020 Apr; 37(2):182-185. PubMed ID: 32730487
[TBL] [Abstract][Full Text] [Related]
7. Bacteremia caused by
Zhang Y; Li K; Zhan Y; Shi L; Zeng Y; Wang H; Lu Z
Front Med (Lausanne); 2023; 10():1283769. PubMed ID: 38131046
[No Abstract] [Full Text] [Related]
8. Maternal peripartum bacteremia caused by intrauterine infection with
Qu H; Zhao YH; Zhu WM; Liu L; Zhu M
World J Clin Cases; 2022 Jul; 10(21):7585-7591. PubMed ID: 36158025
[TBL] [Abstract][Full Text] [Related]
9. First report of
Almuzara M; Cittadini R; Estraviz ML; Ellis A; Vay C
New Microbes New Infect; 2018 Jul; 24():4-7. PubMed ID: 29922468
[TBL] [Abstract][Full Text] [Related]
10. Comamonas kerstersii and the perforated appendix.
Biswas JS; Fitchett J; O'Hara G
J Clin Microbiol; 2014 Aug; 52(8):3134. PubMed ID: 24829228
[No Abstract] [Full Text] [Related]
11. Imipenem/cilastatin sodium/relebactam fixed combination to treat urinary infections and complicated intra-abdominal bacterial infections.
Thakare R; Dasgupta A; Chopra S
Drugs Today (Barc); 2020 Apr; 56(4):241-255. PubMed ID: 32309820
[TBL] [Abstract][Full Text] [Related]
12.
Rong K; Delport J; AlMutawa F
Case Rep Infect Dis; 2022; 2022():1129832. PubMed ID: 35387092
[No Abstract] [Full Text] [Related]
13. Complete genome sequencing of Comamonas kerstersii 8943, a causative agent for peritonitis.
Jiang X; Liu W; Zheng B
Sci Data; 2018 Nov; 5():180222. PubMed ID: 30398469
[TBL] [Abstract][Full Text] [Related]
14. Bacteremia caused by Comamonas kerstersii in a patient with diverticulosis.
Opota O; Ney B; Zanetti G; Jaton K; Greub G; Prod'hom G
J Clin Microbiol; 2014 Mar; 52(3):1009-12. PubMed ID: 24371242
[TBL] [Abstract][Full Text] [Related]
15. Comamonas kerstersii bacteremia.
Liu XJ; Qiao XW; Huang TM; Li L; Jiang SP
Med Mal Infect; 2020 May; 50(3):288-290. PubMed ID: 32169298
[No Abstract] [Full Text] [Related]
16. Septic shock and adequacy of early empiric antibiotics in the emergency department.
Flaherty SK; Weber RL; Chase M; Dugas AF; Graver AM; Salciccioli JD; Cocchi MN; Donnino MW
J Emerg Med; 2014 Nov; 47(5):601-7. PubMed ID: 25218723
[TBL] [Abstract][Full Text] [Related]
17. [First identification in Ecuador of Comamonas kerstersii as an infectious agent].
Farfán-Cano G; Parra-Vera H; Ávila-Choez A; Silva-Rojas G; Farfán-Cano S
Rev Chilena Infectol; 2020 Apr; 37(2):179-181. PubMed ID: 32730486
[TBL] [Abstract][Full Text] [Related]
18. Unusual presentations of
Almuzara M; Barberis C; Veiga F; Bakai R; Cittadini R; Vera Ocampo C; Alonso Serena M; Cohen E; Ramirez MS; Famiglietti A; Stecher D; Del Castillo M; Vay C
New Microbes New Infect; 2017 Sep; 19():91-95. PubMed ID: 28794884
[TBL] [Abstract][Full Text] [Related]
19. Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial.
Portsmouth S; van Veenhuyzen D; Echols R; Machida M; Ferreira JCA; Ariyasu M; Tenke P; Nagata TD
Lancet Infect Dis; 2018 Dec; 18(12):1319-1328. PubMed ID: 30509675
[TBL] [Abstract][Full Text] [Related]
20. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.
Carmeli Y; Armstrong J; Laud PJ; Newell P; Stone G; Wardman A; Gasink LB
Lancet Infect Dis; 2016 Jun; 16(6):661-673. PubMed ID: 27107460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]